SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

The FDA's issuance of a Complete Response Letter (CRL) for Regenxbio's RGX-121 gene therapy for Hunter syndrome is driving intense conversation, with the community expressing significant concerns about the trial design, financial implications, and potential dilution amidst broader scrutiny of gene therapy development.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

FISV is trending intensely ahead of its earnings, with the community sharply divided between those anticipating a strong rebound fueled by perceived undervaluation, recent institutional accumulation, and new leadership's strategic moves, and those fearing another significant drop due to past disappointments, heavy put option activity, and ongoing fintech sector concerns.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl is trending as its stock plunged following the abrupt departures of its CFO and general counsel amid an ongoing accounting review, delayed filings, and a lowered outlook for fiscal 2026. The community is sharply divided between those calling it a "falling knife" and comparing it to past accounting scandals, and dip buyers who believe the sell-off is an "overreaction" given its revenue and stating no material impact to core financials is currently expected.

Silvercorp Metals, Inc. engages in the acquisition, exploration, development, and mining of mineral properties and Environmental, Social and Governance practices. It operates through Mining and Administrative segments. The Mining segment includes Henan Luoning, Guangdong, and others. Its products include Silverbearing lead and Zinc Concentrates.The Administrative segment focuses on Vancouver and Beijing. The company was founded by Rui Feng on October 31, 1991 and is headquartered in Vancouver, Canada.

Silvercorp Metals Inc

Silvercorp Metals Inc.

Silvercorp Metals is trending due to a blowout quarterly earnings report that exceeded estimates, with the community actively discussing its perceived undervaluation and anticipating a significant price surge, bolstered by strong precious metals market conditions.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is currently trending as investors keenly await congressional decisions on ACA subsidies, which could significantly influence its future growth, alongside an upcoming earnings report. Sentiment among the community is polarized, with many bulls anticipating a rally on policy clarity and improved financials, while bears caution about continued losses and sector-wide pressures.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is experiencing significant volatility following its mixed Q4 earnings, which showed an EPS beat but a revenue miss and conservative 2026 guidance prioritizing prudent risk management. While the market is punishing PGY, many in the community view the dramatic sell-off as an extreme overreaction given the company's profitability, strong fundamentals, and historically low valuation compared to peers in the fintech and AI sectors.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON Semiconductor is trending with a notable sell-off after reporting mixed earnings and issuing a soft Q1 outlook, leading to strong community debate on whether market reaction is overdone. While some express concern over perceived "stabilization" in automotive and industrial markets, others point to the company's strategic focus on AI data center power and recent partnerships as potential long-term catalysts.

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases. Its mission is to develop disease-modifying therapeutics that aim to resolve fibrosis and restore organ function, enabling patients with these disorders to live fuller and healthier lives. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium.

AgomAb Therapeutics NV - ADR

AgomAb Therapeutics NV is trending as a new IPO with an extremely low float, fueling intense community discussion about its potential for a short squeeze and rapid price movement, while others anticipate a pullback after its initial run.

Upwork, Inc. is an online marketplace which engages in the provision of businesses to find, hire, and pay freelancers for short-term and longer-term projects. Its marketplace offerings include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The company was founded by Odysseas Tsatalos and Efstratios Karamanlakis in December 2013 and is headquartered in Palo Alto, CA.

Upwork Inc

Upwork is trending following its latest earnings report, which highlighted record Q4 profitability and a revenue beat, but was met with a notable share price decline as forward guidance fell below expectations. The community is keenly debating the role of AI, weighing Upwork's deep integration and its platform's use in OpenAI's new SWE-Lancer benchmark against broader concerns about AI's potential to disrupt the gig economy.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology Group (CRDO) is surging after pre-announcing preliminary Q3 revenue significantly above prior guidance and consensus, coupled with a robust outlook for sequential growth into fiscal year 2027. The community is vigorously discussing this strong performance, highlighting its crucial role in the ongoing AI data center buildout and the massive capital expenditure increases from hyperscalers, expecting continued upward momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Scilex (NASDAQ:SCLX) Trading Up 8.8% - Time to Buy?

Scilex (NASDAQ:SCLX) Trading Up 8.8% - What's Next...

Scilex (NASDAQ:SCLX) Stock Price Down 3% - Time to Sell?

Scilex (NASDAQ:SCLX) Shares Down 3% - Time to Sell...

Scilex (NASDAQ:SCLX) Stock Price Down 1.3% - Time to Sell?

Scilex (NASDAQ:SCLX) Shares Down 1.3% - What's Next...

<ul class="summary-bullets"><li>The first tranche in September 2025 was $8 million in Bitcoin.</li><li>The second tranche of $141.93 million brings the total investment to $150 million.</li><li>Datavault said the funds will boost digital asset reserves, supercomputing, platform growth, and new revenue streams.</li></ul>Datavault AI (DVLT) announced on Wednesday that it has closed the second tranche of a strategic Bitcoin (BTC)-backed investment from Scilex (SCLX), securing capital to expand its digital asset reserves.In this deal, Scilex used 1,237.6 Bitcoin (BTC) to receive a pre-funded warrant that can be converted into roughly 264 million Datavault shares.&nbsp;In total, Scilex is expected to receive approximately 278.9 million Datavault shares, including 15 million in common stock from the first tranche of investment.The first tranche of the investment, completed in September 2025, was also made in Bitcoin and valued at about $8 million.&nbsp;With the $141.93 million second tranche, the combined investment totals approximately $150 million.&nbsp;Datavault said the investment will help it grow its digital asset reserves, expand supercomputing infrastructure, develop its platform, and create new revenue opportunities.&nbsp;<h2 class="st-heading-2">The Market Reaction</h2>Scilex Holding Company and Datavault partnered in September following Scilex’s $150 million investment. In addition to the capital infusion, Scilex secured a worldwide exclusive license reportedly valued at up to $10 million for Datavault’s AI and tokenization technology, focused on monetizing real-world assets and data, particularly in biotech and healthcare.<a href="https://stocktwits.com/symbol/SCLX">SCLX’s stock</a> dropped as much as 3.65% in pre-market trade despite strength in the broader market. On Stocktwits, it was among the top trending tickers. Data showed retail sentiment around the company rose to ‘extremely bullish’ from ‘bullish’ territory, accompanied by ‘high’ levels of chatter over the past day.&nbsp;<a href="https://stocktwits.com/symbol/DVLT">DVLT’s stock</a> edged 0.4% lower, with retail sentiment around the firm improving to ‘bullish’ from ‘neutral’ over the past day, with chatter at ‘high’ levels.<h2 class="st-heading-2">What Is Retail Thinking?</h2>One bullish user on Stocktwits said Scliex’s position in Datavault is now worth more than the original $150 million investment.&nbsp;<stembedurl>https://stocktwits.com/Sacsofcash/message/637487414</stembedurl>Another bullish trader anticipates ample runway ahead for the stock’s price to gain.<stembedurl>https://stocktwits.com/ToxicAvenger/message/637491996</stembedurl>SCLX’s stock has gained more than 30% this year, while DVLT’s stock has gained almost 10%.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-xrp-ada-struggle-ahead-of-thanksgiving-analyst-warns-no-catalyst/cL53V2sREWP">Bitcoin, XRP, ADA Struggle Ahead Of Thanksgiving – Analyst Warns There’s No Clear Catalyst For Q4</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of Bitcoin with stock market data. (Source: Andriy Onufriyenko/Getty Images)

Scilex Injects More Bitcoin Into Datavault AI, Unlocks 264M Share Warrant Issue

Retail sentiment on Stocktwits around both stocks rose over the past day, despite slight pre-market share price declines.

Equity

<ul class="summary-bullets"><li>Record shareholders of Scilex Holding Company will also be eligible for the meme coin airdrop.</li><li>Datavault AI described the decision as a gesture of appreciation for Scilex’s role as a stockholder, licensing partner, and co-sponsor of Dream Bowl XIV.</li><li>The board retains the right to alter the record date or revoke the airdrop before distribution based on solvency or surplus considerations.</li></ul>Datavault AI (DVLT) traded higher in pre-market hours on Monday after announcing that record shareholders as of today will qualify for its Dream Bowl 2026 meme coin airdrop set for January.<a href="https://stocktwits.com/symbol/DVLT/">DVLT’s stock</a> rose as much as 2.75% in pre-market trade. On Stocktwits, retail sentiment around the company dipped to ‘neutral’ from ‘bullish’ territory over the past day. To qualify for the distribution, holders must own Datavault AI shares as of the record date of November 25, 2025, the company said Friday.<h2 class="st-heading-2">Scilex Equity Holders Included in Airdrop Plan</h2>The company also said the airdrop will extend to record holders of Scilex Holding Company (SCLX) common stock. Datavault AI described the decision as a gesture of appreciation for Scilex’s role as a stockholder, licensing partner, and co-sponsor of Dream Bowl XIV, which is scheduled for January 11, 2026.<a href="https://stocktwits.com/symbol/SCLX">SCLX’s stock</a> rose as much as 18% in pre-market trade but later reversed, moving nearly 5% lower as the market open approached. On Stocktwits, retail sentiment around the stock remained in ‘bullish’ territory, with chatter at ‘high’ levels.<h2 class="st-heading-2">Distribution Terms and Board Discretion</h2>Datavault AI said the Dream Bowl 2026 Meme Coins will be distributed to Data Vault wallets after the payment date, provided recipients elect to opt in, set up a digital wallet, and supply the required documentation.The company added that its Board of Directors may change the record date at any time before the payment date. The distribution remains subject to the Board’s approval and may be revoked, including in the event of a material change to the solvency or surplus analysis previously presented.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/btc-holds-86000-crypto-market-back-above-3-trillion-xrp-doge-gain/cL5bex0REQP">Bitcoin Holds $86,000 With Crypto Market Back Above $3 Trillion – XRP, Doge Gain Ahead Of Grayscale’s New ETF Launches</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Datavault AI logo is seen displayed on a smartphone screen.

DVLT Shares Rise In Pre-Market On Upcoming Meme Coin Distribution For Record Shareholders

Record shareholders as of Monday will be eligible to receive the airdrop, scheduled for January.

Scilex (NASDAQ:SCLX) Posts Earnings Results, Misses Expectations By $21.76 EPS

Scilex (NASDAQ:SCLX - Get Free Report) announced its quarterly earnings results on Friday. The company reported ($22.17) earnings per share (EPS) for the quarter, missing the consensus estimate of...

Scilex Holding Company (SCLX) on Thursday said that its majority-owned subsidiary, Semnur Pharmaceuticals, and Denali Capital Acquisition Corp (DECA) have entered into a purchase agreement with an investor for a $20 million private placement.The proceeds of the <a target="_blank" rel="noopener noreferrer nofollow" href="https://scilexholding.gcs-web.com/node/10161/pdf">agreement</a> will be used to advance the second late-stage clinical trial for the development of SP-102, a viscous gel formulation of a widely used corticosteroid for epidural injections, for the treatment of lumbosacral radicular pain. Lumbosacral radicular pain, often referred to as sciatica, is a pain that radiates along the sciatic nerve, which extends from the lower back down the leg.On Stocktwits, retail sentiment around Scilex remained within the ‘neutral’ territory over the past 24 hours, while message volume fell from ‘normal’ to ‘low’ levels. <a href="https://stocktwits.com/symbol/SCLX">SCLX stock</a> is trading 0.5% lower in the pre-market session at the time of writing.<figure class="image"><img style="aspect-ratio:567/60;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_21_at_7_24_17_AM_png_36aea133ff.webp" alt="SCLX's Sentiment Meter and Message Volume as of 7:24 a.m. ET on Aug. 21, 2025 | Source: Stocktwits" width="567" height="60"><figcaption>SCLX's Sentiment Meter and Message Volume as of 7:24 a.m. ET on Aug. 21, 2025 | Source: Stocktwits</figcaption></figure>Semnur and special purpose acquisition company (SPAC) Denali entered into a <a target="_blank" rel="noopener noreferrer nofollow" href="https://scilexholding.gcs-web.com/node/9226/pdf">plan of merger</a> on Aug. 30, 2024, for a proposed business combination, among Semnur, the SPAC, and the SPAC's unit Denali Merger Sub Inc. This provided for a pre-transaction equity value of Semnur at $2.5 billion.&nbsp;Under the deal, the combined company will be renamed Semnur Pharmaceuticals, Inc., and its common stock is expected to be listed on Nasdaq under the ticker symbol “SMNR”. The combination is now expected to close in September 2025.An investor has agreed to purchase an aggregate of 1.25 million shares of common stock of the combined company following the consummation of the merger transaction, Scilex said. The purchase price for the placement is $16.00 per share, for an aggregate purchase price of $20 million.The closing of the financing is subject to customary conditions and is expected to occur immediately following the consummation of the business combination, Scilex said.The company also said that CEO Jaisim Shah resigned as Scilex CEO and will now serve as chief executive and President of Semnur. Henry Ji, who currently serves as Executive Chairman of Scilex, was appointed as Scilex’s new CEO and President and has assumed all of the duties formerly performed by Shah, the company said.SCLX stock is up by 18% this year and down by 60% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/cryptocurrency/two-players-quietly-took-over-bitcoin-mining-power-heres-why-it-matters/chsSu9WRdi5">Two Players Quietly Took Over Bitcoin’s Mining Power — Here’s Why It Matters</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

Scilex Subsidiary Semnur Pharma Eyes $20M Private Placement Deal: More Details Inside

The proceeds of the agreement will be used to advance the second late-stage clinical trial for the development of SP-102, a viscous gel formulation of a widely used corticosteroid for epidural injections, for the treatment of lumbosacral radicular pain.

Scilex Holding Co. (SCLX), a relatively under-the-radar player in the non-opioid pain management space, has unexpectedly captured the attention of retail investors. The company experienced a staggering 41.78% increase in retail followers on Stocktwits over the past month, despite a 21% decline in its share price.However, the initial bullish sentiment has waned, with Stocktwits sentiment flipping to bearish (36/100) and message volumes surging. This shift suggests growing investor skepticism amidst recent company developments.<figure class="image"><img style="aspect-ratio:1316/306;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/SCLX_Sentiment_and_message_score_Aug_1_f79a43cdac.png" alt="SCLX Sentiment and message score Aug 1.png" width="1316" height="306"><figcaption>SCLX Sentiment and message score Aug 1</figcaption></figure>The surge in retail interest can be attributed to several factors. Primarily, the announcement of a potential $2 billion deal for its subsidiary, Semnur Pharmaceuticals, to go public through a SPAC merger with Denali Capital Acquisition Corp (DECA) has generated excitement. The proceeds from this deal are earmarked for the development of SP-102, a key drug candidate in late-stage trials.Additionally, Scilex had reported preliminary Q2 net sales above estimates, indicating revenue growth. However, a significant decline in cash and cash equivalents raised concerns.The company also entered into a collaboration agreement with ACEA for the potential expansion of its ZTlido treatment, used to help relieve nerve pain after shingles, in the Greater China region.While July saw continued sales growth for ZTlido, the pace of growth slowed compared to the previous month. This, coupled with the overall bearish sentiment and declining cash reserves, seems to have tempered initial enthusiasm.With Q2 earnings report scheduled for August 9th after market hours, investors will be closely watching for further clarity on the company's financial health and the progress of its key initiatives.Photo via Vecteezy

Small-Cap Scilex Drew Biggest Jump In Retail Following For July: What Drove It?

Retail investors flocked to Scilex, drawn by news about a lucrative SPAC deal for its unit, declining cash reserves and slowing sales growth.

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTLido, Elyxyb, and Gloperba. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Scilex Holding Company

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

Current Price	$8.61
Prev Close	$8.49
Open	$8.48
Dividend Yield	0.00%
50-Day Moving Average	$13.72
Beta	1.13
Avg. Volume	81,642.15
PE Ratio	-0.26

52-Week High	$34.27
52-Week Low	$3.60
Market Capitalization	$582.07M
EPS (Annual)	-$19.43
Price to Book	-0.29
Revenue Per Employee	$492,086.96
Enterprise Value/EBITDA	N/A

SCLX
Scilex Holding Company

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SCLX News

SCLXScilex Holding Company